NCT02740894View on ClinicalTrials.gov

Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?

Interventions

DRUG

Gefitinib

All Listed Sponsors

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT02740894 - Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ? | Biotech Hunter | Biotech Hunter